Primus Remedies

Hyderabad, India Founded: 2010 • Age: 16 yrs
Manufacturing and supplying therapeutic drugs in healthcare segments like diabetology and cardiology.

About Primus Remedies

Primus Remedies is a Government & Social Sector company based in Hyderabad (India) founded in 2010. Manufacturing and supplying therapeutic drugs in healthcare segments like diabetology and cardiology. It operates in the Government & Social Sector and Healthcare sectors. The company has 292 employees. Its Indian entity Primus Remedies Private Limited reported revenue of β‚Ή115 Cr. Primus Remedies offers products and services including Diabetes Management Drugs and Hypertension Management Drugs. Its focus areas include Medical Services, Corporate Social Responsibility, Health Awareness Programs and Pharmaceuticals.

Company details

Primus Remedies is known for providing cost-effective and safe therapeutic drugs across segments such as cardiology, diabetology, and endocrinology, with manufacturing that adheres to WHO GMP standards to ensure quality and efficacy. Corporate social responsibility is emphasized through the establishment of the Diabetes Awareness Foundation, which has facilitated numerous health camps, exhibitions, and educational programs to raise awareness about diabetes prevention and management. The companys efforts are directed towards upgrading products to combat emerging diseases, focusing on patient well-being and continuous improvement in the pharmaceutical sector.

  • Headquarters Hyderabad, India
  • Employees 292
  • Sectors
    Government & Social Sector
    Healthcare
  • Website primusremedies.com
  • Legal Name Primus Remedies Pvt Ltd
  • Date of Incorporation 26 Feb, 2010
  • Jurisdiction Dombivili, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹115 Cr

    FY 2025 · +14% YoY

  • Net Profit
    ₹8.73 Cr

    FY 2025 · 8% margin

  • EBITDA
    ₹12.47 Cr

    FY 2025 · 11% margin

  • Employee Count
    292

Products & Services of Primus Remedies

Primus Remedies offers a comprehensive portfolio of products and services, including Diabetes Management Drugs and Hypertension Management Drugs.

Diabetes Management Drugs
Therapeutic Drugs

Medicinal products for diabetes management are supplied by Primus Remedies, including formulations like Metformin and Dapagliflozin, which are designed to address metabolic disorders effectively.

Hypertension Management Drugs
Therapeutic Drugs

Drugs for hypertension management are provided by Primus Remedies, such as Telmisartan and Olmesartan, which are formulated to meet healthcare needs in cardiology segments.

Board of directors of Primus Remedies Private Limited (Primus Remedies)

Primus Remedies Private Limited is the primary company behind Primus Remedies. The board of Primus Remedies Private Limited currently have 8 directors; the longest-serving is Srinivas Gangashettywar, appointed in 2010.

DirectorDesignationAppointedTenureEntity
Srinivas Gangashettywar
DIN 02954408
Director26 Feb 201016 yrs 8 moPrimus Remedies Private Limited
Swapna Pasupunuri
DIN 02929202
Director26 Feb 201016 yrs 8 moPrimus Remedies Private Limited
Ajay Babu Narayanam
DIN 02929155
Director26 Feb 201016 yrs 8 moPrimus Remedies Private Limited
Sridevi Jonnalagadda
DIN 02934051
Director26 Feb 201016 yrs 8 moPrimus Remedies Private Limited
Rakesh Pasupunuri
DIN 09628372
Director03 Jun 20224 yrs 5 moPrimus Remedies Private Limited
Jonnalagadda Venkata Nagendraprasad
DIN 09628351
Director03 Jun 20224 yrs 5 moPrimus Remedies Private Limited
Kavitha Gangashettwar
DIN 09628416
Director03 Jun 20224 yrs 5 moPrimus Remedies Private Limited
Satya Surya Purna Prasanthi Narayanam
DIN 09628389
Director03 Jun 20224 yrs 5 moPrimus Remedies Private Limited

Financials of Primus Remedies

Figures of Primus Remedies Private Limited, the primary company behind Primus Remedies, for FY 2025. Revenue was ₹115 Cr (+14% year on year). Net profit was ₹8.73 Cr (8% margin). EBITDA was ₹12.47 Cr (11% margin). Revenue has grown at a compounded annual rate of +19% over three years and +27% over five years.

  • ₹115 CrRevenue · FY 2025 · +14% YoY
  • ₹8.73 CrNet profit · 8% margin
  • ₹12.47 CrEBITDA · 11% margin
  • ₹1 LakhPaid-up capital
  • 292Employees (provident fund records)
  • +19%Revenue CAGR, 3 years
  • +27%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Primus Remedies Private Limited are on its company page.

Premium access

Detailed financial statements for Primus Remedies

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Primus Remedies

Primus Remedies was founded in 2010.

Primus Remedies is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Primus Remedies has 292 employees.

The primary company behind Primus Remedies, Primus Remedies Private Limited, reported revenue of β‚Ή115 Cr for FY 2025, up 14% year on year.

Primus Remedies is known for providing cost-effective and safe therapeutic drugs across segments such as cardiology, diabetology, and endocrinology, with manufacturing that adheres to WHO GMP standards to ensure quality and efficacy. Corporate social responsibility is emphasized through the establishment of the Diabetes Awareness Foundation, which has facilitated numerous health camps, exhibitions, and educational programs to raise awareness about diabetes prevention and management. The companys efforts are directed towards upgrading products to combat emerging diseases, focusing on patient well-being and continuous improvement in the pharmaceutical sector.

Primus Remedies offers Diabetes Management Drugs and Hypertension Management Drugs.

Primus Remedies operates through Primus Remedies Private Limited.

The legal entities of Primus Remedies currently have 8 directors, including Srinivas Gangashettywar, Rakesh Pasupunuri, Jonnalagadda Venkata Nagendraprasad and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available